![Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors - RSC Advances (RSC Publishing) DOI:10.1039/C5RA02365C Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors - RSC Advances (RSC Publishing) DOI:10.1039/C5RA02365C](https://pubs.rsc.org/image/article/2015/RA/c5ra02365c/c5ra02365c-f1_hi-res.gif)
Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors - RSC Advances (RSC Publishing) DOI:10.1039/C5RA02365C
![Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors - RSC Advances (RSC Publishing) DOI:10.1039/C5RA02365C Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors - RSC Advances (RSC Publishing) DOI:10.1039/C5RA02365C](https://pubs.rsc.org/image/article/2015/RA/c5ra02365c/c5ra02365c-f6_hi-res.gif)
Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors - RSC Advances (RSC Publishing) DOI:10.1039/C5RA02365C
![Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma. - Abstract - Europe PMC Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7649750/bin/nihms-1639629-f0001.jpg)
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma. - Abstract - Europe PMC
![IJMS | Free Full-Text | Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development IJMS | Free Full-Text | Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development](https://pub.mdpi-res.com/ijms/ijms-20-05260/article_deploy/html/images/ijms-20-05260-g009.png?1573827761)
IJMS | Free Full-Text | Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
![IJMS | Free Full-Text | Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development IJMS | Free Full-Text | Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development](https://www.mdpi.com/ijms/ijms-20-05260/article_deploy/html/images/ijms-20-05260-g003.png)
IJMS | Free Full-Text | Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition | PLOS ONE
![Synthesis and biological evaluation of benzomorpholine derivatives as novel EZH2 inhibitors for anti-non-small cell lung cancer activity | SpringerLink Synthesis and biological evaluation of benzomorpholine derivatives as novel EZH2 inhibitors for anti-non-small cell lung cancer activity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11030-018-9903-7/MediaObjects/11030_2018_9903_Fig1_HTML.png)
Synthesis and biological evaluation of benzomorpholine derivatives as novel EZH2 inhibitors for anti-non-small cell lung cancer activity | SpringerLink
Full article: Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies
![High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2 - ScienceDirect High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021925820310048-gr5.jpg)
High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2 - ScienceDirect
![EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation - ScienceDirect EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074552114003421-fx1.jpg)
EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation - ScienceDirect
EZH2 Inhibitor Efficacy in Non-Hodgkin's Lymphoma Does Not Require Suppression of H3K27 Monomethylation
![Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma - ScienceDirect Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720312821-gr1.jpg)